What is Dexamethasone, the 1st drug UK scientists say can reduce COVID-19 deaths?
Oxford University trial shows low-cost steroid drug ‘dexamethasone’ reduced COVID-19 deaths by up to one-third in severely-ill ventilated patients. Anti-inflammatory medicine dexamethasone is used since early 1960s to treat conditions like rheumatoid arthritis and asthma. A total of 2,104 patients received 6mg dexamethasone for ten days and were compared with 4,321 patients receiving usual care.
Dexamethasone, a low-cost steroid, reduces the risk of dying from coronavirus by a third in patients on ventilators and by one fifth in other patients receiving oxygen only, a British trial found. “Dexamethasone is the first drug to be shown to improve survival,” a chief investigator for the trial said. The scientists described dexamethasone’s use as a “major breakthrough”. Dexamethasone 1st drug to reduce deaths in patients with severe COVID-19, trial shows
- Molar mass: 392.464 g/mol
- CAS ID: 50-02-2
- Formula: C22H29FO5
- Elimination half-life: 190 minutes (3.2 hours)
- Metabolism: Liver
- Melting point: 262 °C (504 °F)
- Bioavailability: 80–90%
Dexamethasone is a type of corticosteroid medication. It is used in the treatment of many conditions, including rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following eye surgery, and along with antibiotics in tuberculosis. Wikipedia
Keep reading TechBrainism